| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M709824200 |
| P8608 | Fatcat ID | release_kfblijet6vehljnnnfj5z7tnrm |
| P3181 | OpenCitations bibliographic resource ID | 2027377 |
| P932 | PMC publication ID | 2417170 |
| P698 | PubMed publication ID | 18211898 |
| P50 | author | Carolyn Coyne | Q28754337 |
| P2093 | author name string | Simon C Watkins | |
| Wei Yang | |||
| Jing Jin | |||
| Tianyi Wang | |||
| Ronald C Montelaro | |||
| Nabanita Biswas | |||
| Chao Qiu | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape | Q24307684 | ||
| The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus | Q24307963 | ||
| A small rab GTPase is distributed in cytoplasmic vesicles in non polarized cells but colocalizes with the tight junction marker ZO-1 in polarized epithelial cells | Q24336878 | ||
| Structure-function analysis of hepatitis C virus envelope-CD81 binding | Q24525189 | ||
| Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5 | Q24658142 | ||
| Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes | Q24673768 | ||
| Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin | Q24682664 | ||
| The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum | Q27469349 | ||
| A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. | Q27469530 | ||
| Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins | Q27469653 | ||
| Robust hepatitis C virus infection in vitro | Q27470013 | ||
| Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells | Q27472707 | ||
| Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis | Q27473290 | ||
| Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles | Q27477644 | ||
| Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles | Q27477687 | ||
| Effect of Cell Polarization on Hepatitis C Virus Entry | Q27485293 | ||
| CD81-Dependent Binding of Hepatitis C Virus E1E2 Heterodimers | Q27485659 | ||
| The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization | Q27622511 | ||
| Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
| Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry | Q28131832 | ||
| Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein | Q28141954 | ||
| Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 | ||
| Claudin-1 is not restricted to tight junctions in the rat epididymis | Q28570966 | ||
| CD81 is an entry coreceptor for hepatitis C virus | Q29614812 | ||
| CD81 is required for hepatitis C virus glycoprotein-mediated viral infection | Q29619745 | ||
| Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer | Q33853447 | ||
| Distinct roles of Rab3B and Rab13 in the polarized transport of apical, basolateral, and tight junctional membrane proteins to the plasma membrane | Q34220077 | ||
| How does hepatitis C virus enter cells? | Q34560646 | ||
| Endocytosis of Epithelial Apical Junctional Proteins by a Clathrin-mediated Pathway into a Unique Storage Compartment | Q34786013 | ||
| The tight junction: a multifunctional complex | Q35777543 | ||
| The molecular physiology of tight junction pores | Q35952151 | ||
| Cell entry of hepatitis C virus | Q36385222 | ||
| Hepatitis C virus entry: potential receptors and their biological functions | Q36444205 | ||
| Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays. | Q40096523 | ||
| A novel cysteine cross-linking method reveals a direct association between claudin-1 and tetraspanin CD9. | Q40103786 | ||
| Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis | Q40246185 | ||
| Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process | Q40415725 | ||
| Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. | Q40481063 | ||
| Inhibition of lung carcinoma cell growth by high density lipoprotein-associated alpha-tocopheryl-succinate | Q40545218 | ||
| High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion | Q40812887 | ||
| Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha | Q43048874 | ||
| Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions | Q45420840 | ||
| Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. | Q50740719 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 8643-53 | |
| P577 | publication date | 2008-03-28 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Correlation of the Tight Junction-like Distribution of Claudin-1 to the Cellular Tropism of Hepatitis C Virus | |
| P478 | volume | 283 |
| Q36540898 | A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway |
| Q34179353 | A human claudin-1-derived peptide inhibits hepatitis C virus entry |
| Q35598686 | A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3. |
| Q33628805 | Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. |
| Q57241788 | Blocking HCV entry as potential antiviral therapy |
| Q27486789 | CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes |
| Q27485899 | CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry |
| Q37611819 | CD81 and hepatitis C virus (HCV) infection. |
| Q37611842 | CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies. |
| Q50320977 | Carboxyl-terminal Tail-mediated Homodimerizations of Sphingomyelin Synthases Are Responsible for Efficient Export from the Endoplasmic Reticulum. |
| Q37514366 | Cellular and molecular biology of HCV infection and hepatitis |
| Q29465808 | Claudin association with CD81 defines hepatitis C virus entry. |
| Q39019295 | Claudins in viral infection: from entry to spread |
| Q91638491 | Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels |
| Q34672966 | Discovery of cellular proteins required for the early steps of HCV infection using integrative genomics |
| Q52332712 | Disruption of Claudin-1 Expression by miRNA-182 Alters the Susceptibility to Viral Infectivity in HCV Cell Models. |
| Q90581399 | Distinct Origin of Claudin7 in Early Tumor Endosomes Affects Exosome Assembly |
| Q64231849 | Early Porcine Sapovirus Infection Disrupts Tight Junctions and Uses Occludin as a Coreceptor |
| Q45366167 | Examination of claudin-1 expression in patients undergoing liver transplantation owing to hepatitis C virus cirrhosis |
| Q36171910 | Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus |
| Q43035286 | Expression profiles of genes associated with viral entry in HCV-infected human liver |
| Q27487550 | Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production |
| Q40225424 | Fusion expression of Occludin extracellular loops and an α-helical bundle: A new research model for tight junction |
| Q33916208 | Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes |
| Q57564402 | HCV Receptors and Virus Entry |
| Q37856393 | Hepatitis C virus entry and the tetraspanin CD81. |
| Q39938116 | Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum. |
| Q30512696 | Hepatitis C virus induces CD81 and claudin-1 endocytosis |
| Q27490466 | Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization |
| Q37123557 | High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1. |
| Q33880854 | Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of Flaviviridae |
| Q36001172 | Identification of a Potent and Broad-Spectrum Hepatitis C Virus Fusion Inhibitory Peptide from the E2 Stem Domain |
| Q35503745 | Impenetrable barriers or entry portals? The role of cell-cell adhesion during infection |
| Q42978863 | Implication of tetraspanin-enriched microdomains (TEMs) in hepatitis C virus |
| Q41887493 | In vitro systems for the study of hepatitis C virus infection |
| Q52598001 | Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. |
| Q42279087 | Insilico modeling and molecular dynamic simulation of claudin-1 point mutations in HCV infection. |
| Q37688134 | Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches |
| Q27314798 | Listeria monocytogenes internalin B activates junctional endocytosis to accelerate intestinal invasion |
| Q22252690 | Mechanisms of viral entry: sneaking in the front door |
| Q27490526 | Mouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell Line |
| Q33433004 | Omic analyses unravels global molecular changes in the brain and liver of a rat model for chronic Sake (Japanese alcoholic beverage) intake. |
| Q24318390 | Phospholipid scramblase 1 mediates hepatitis C virus entry into host cells |
| Q27488433 | Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells |
| Q37352203 | Primary hepatocytes as targets for hepatitis C virus replication |
| Q27486784 | Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and Infectivity |
| Q27488396 | Residues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell Contacts |
| Q38156851 | Roles of the two distinct proteasome pathways in hepatitis C virus infection |
| Q36559811 | Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A. |
| Q36105419 | Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins |
| Q34296017 | Species-specific regions of occludin required by hepatitis C virus for cell entry |
| Q34087743 | Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells |
| Q36533706 | Targeting of tetraspanin proteins--potential benefits and strategies |
| Q27485588 | The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry |
| Q56944979 | The Involvement of Tight Junction Protein Claudin-1 in Hepatitis C Virus Entry |
| Q33719403 | The SR-BI partner PDZK1 facilitates hepatitis C virus entry. |
| Q39658657 | The second extracellular loop dictates Occludin-mediated HCV entry |
| Q27487947 | Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection |
| Q42978515 | When one receptor closes, another opens: claudins and the hepatitis C virus E1 glycoprotein. |
Search more.